Latest From Biotech Now

GMO Answers Marks October as “Get to Know GMOs” Month

GMO Answers

GMO Answers has announced that for the month of October we are inviting the public to “Get to Know GMOs” – to ask their toughest questions and join the conversation. This month GMO Answers will be engaging online and across social media to help consumers Get to Know GMOs and better understand the role of biotechnology in agriculture. As others promote activities opposing GMOs throughout October, we’ll be correcting common misconceptions and introducing consumers to those Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , ,

Should the USPTO Allow the Patenting of Living Organisms?

US PTO

Last year, a question was submitted to the GMO advocacy website GMOAnswers about whether or not the USPTO should allow the patenting of living organisms. Under 35 U.S.C. 101, “the laws of nature, physical phenomena, and abstract ideas have been held not patentable.” Therefore the USPTO cannot and does not award patents on living organisms that were merely discovered in nature. However, the U.S. Supreme Court Ruled in Diamond v. Chakrabarty that a “nonnaturally occurring Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Cutting Through the Food Labeling Confusion

Food Labels

There was a lot of media buzz around a Consumer Reports study released yesterday that shows confusion around foods labeled “natural.” We agree that food labels can be confusing.  And that’s why we are part of a coalition of farm-to-fork organizations that support a federal legislative solution that will protect consumers by eliminating confusion around food labels while advancing food safety. In addition to requiring federal standards for companies that want to voluntarily label their Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Tekmira CEO

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a conversation with Phyllis Arthur, BIO’s Senior Director for Vaccines, Immunotherapeutics, and Diagnostics Policy. Tekmira has been in the spotlight recently due to their experimental Ebola therapy, TKM-Ebola. Recently, they announced that FDA has allowed them to provide TKM-Ebola for treatment under expanded access protocols, and that they have joined an international consortium to conduct clinical trials of Ebola virus therapeutics Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Fireside Chat with Ken Drazan, MD, Head of Johnson & Johnson Innovation

Ken Drazan, MD

Day one of the BIO Investor Forum featured a Fireside Chat with Ken Drazan, MD, who serves as the head of Johnson & Johnson Innovation in California. The conversation was moderated by Deepa R. Pakianathan, PhD, a general partner for Delphi Ventures who leads the firm’s biotechnology investment activities. Ken Drazan has a unique viewpoint which results from having experience with both the biopharma start-up world as well as in the investment community. This background Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,